- Report
- October 2022
- 110 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- January 2026
- 187 Pages
Japan
From €2243EUR$2,500USD£1,917GBP
- Report
- July 2025
- 217 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- June 2025
- 209 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- June 2025
- 229 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- September 2024
- 173 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- August 2024
- 170 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- August 2024
- 168 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- August 2024
- 184 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- July 2024
- 182 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- March 2024
- 170 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- February 2024
- 150 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- November 2023
- 166 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- July 2021
- 120 Pages
Global
From €2243EUR$2,500USD£1,917GBP
From €2243EUR$2,500USD£1,917GBP
- Report
- June 2024
- 183 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- June 2026
- 121 Pages
Mexico
From €2690EUR$2,999USD£2,300GBP
- Report
- June 2026
- 115 Pages
Mexico
From €2690EUR$2,999USD£2,300GBP
- Report
- June 2026
- 121 Pages
Mexico
From €2690EUR$2,999USD£2,300GBP
€3587EUR$3,999USD£3,067GBP
- Report
- March 2023
- 350 Pages
Europe
From €2690EUR$2,999USD£2,300GBP
€3587EUR$3,999USD£3,067GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more